{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T02:19:14Z","timestamp":1789265954400,"version":"build-2803163510"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>To report the first case of belatacept-associated multidrug-resistant Cytomegalovirus retinitis in a kidney transplant recipient.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 76-year-old African male renal allograft recipient was admitted for acute visual loss of the right eye. Ophthalmological examination of the right eye showed anterior uveitis and vitritis associated with large paravascular haemorrhages and yellow necrotic borders, involving the posterior pole but not the fovea. Both Cytomegalovirus DNA in plasma and aqueous humor were positive. The patient had had several episodes of Cytomegalovirus reactivation subsequent to the introduction of belatacept. His cytomegalovirus was multi-drug resistant, and was treated with maribarir, intravitreal and systemic injections of foscarnet, and anti-Cytomegalovirus human immunoglobulin. In parallel, belatacept was stopped and switched to tacrolimus. Cytomegalovirus DNA became undetectable and there was partial improvement of visual acuity at the last ophthalmologic examination, 18\u2009months after the initial diagnosis of Cytomegalovirus retinitis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Cytomegalovirus retinitis is an uncommon opportunistic infection in kidney transplant recipients. Cytomegalovirus retinitis is a serious infection because of the risk of blindness and the occurrence of associated life-threatening opportunistic infections. In view of the recent literature, kidney transplant recipients treated by belatacept immunosuppression may be at increased risk for Cytomegalovirus disease, notably Cytomegalovirus retinitis. The occurrence of Cytomegalovirus retinitis may help improve the selection of patients converted to belatacept.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12886-020-01741-1","type":"journal-article","created":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T01:02:33Z","timestamp":1606784553000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Belatacept associated - cytomegalovirus retinitis in a kidney transplant recipient: a case report and review of the literature"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5885-2877","authenticated-orcid":false,"given":"Pierre-Guillaume","family":"Deli\u00e8ge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine","family":"Bastien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laetitia","family":"Mokri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Guyot-Colosio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Arndt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Rieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,1]]},"reference":[{"issue":"1","key":"1741_CR1","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1053\/j.ajkd.2011.04.010","volume":"58","author":"K De Keyzer","year":"2011","unstructured":"De Keyzer K, Van Laecke S, Peeters P, et al. Human cytomegalovirus and kidney transplantation: a clinician\u2019s update. Am J Kidney Dis. 2011;58(1):118\u201326.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"1741_CR2","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1128\/CMR.00034-08","volume":"22","author":"T Crough","year":"2009","unstructured":"Crough T, Khanna R. Immunobiology of human cytomegalovirus: from bench to bedside. Clin Microbiol Rev. 2009;22(1):76\u201398.","journal-title":"Clin Microbiol Rev"},{"issue":"5","key":"1741_CR3","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/j.transproceed.2006.02.132","volume":"38","author":"YA Akova","year":"2006","unstructured":"Akova YA, Altan-Yaycioglu R, Yilmaz G, et al. Opportunistic posterior uveal infections in renal transplant patients. Transplant Proc. 2006;38(5):1348\u201353.","journal-title":"Transplant Proc"},{"issue":"1","key":"1741_CR4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1399-3062.2007.00241.x","volume":"10","author":"AJ Eid","year":"2008","unstructured":"Eid AJ, Bakri SJ, Kijpittayarit S, et al. Clinical features and outcomes of cytomegalovirus retinitis after transplantation. Transpl Infect Dis. 2008;10(1):13\u20138.","journal-title":"Transpl Infect Dis"},{"issue":"1","key":"1741_CR5","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/j.1399-3062.2006.00128.x","volume":"8","author":"ME Levi","year":"2006","unstructured":"Levi ME, Mandava N, Chan LK, et al. Treatment of multidrug-resistant cytomegalovirus retinitis with systemically administered leflunomide. Transpl Infect Dis. 2006;8(1):38\u201343.","journal-title":"Transpl Infect Dis"},{"issue":"7","key":"1741_CR6","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1016\/j.transproceed.2004.08.049","volume":"36","author":"SB Park","year":"2004","unstructured":"Park SB, Kang MJ, Whang EA, et al. A case of fungal sepsis due to aspergillus spondylitis followed by cytomegalovirus infection in a renal transplant recipient. Transplant Proc. 2004;36(7):2154\u20135.","journal-title":"Transplant Proc"},{"issue":"Suppl 1","key":"1741_CR7","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/nep.12767","volume":"21","author":"D Iwami","year":"2016","unstructured":"Iwami D, Ogawa Y, Fujita H, et al. Successful treatment with foscarnet for ganciclovir-resistant cytomegalovirus infection in a kidney transplant recipient: a case report. Nephrology. 2016;21(Suppl 1):63\u20136.","journal-title":"Nephrology"},{"issue":"4","key":"1741_CR8","first-page":"495","volume":"16","author":"M Hamouda","year":"2018","unstructured":"Hamouda M, Kahloun R, Jaballah L, et al. Cytomegalovirus ocular involvement in a kidney transplant recipient. Exp Clin Transplant. 2018;16(4):495\u20138.","journal-title":"Exp Clin Transplant"},{"issue":"5","key":"1741_CR9","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1016\/S0041-1345(02)03079-8","volume":"34","author":"M Shimakawa","year":"2002","unstructured":"Shimakawa M, Kono C, Nagai T, et al. CMV retinitis after renal transplantation. Transplant Proc. 2002;34(5):1790\u20132.","journal-title":"Transplant Proc"},{"issue":"4","key":"1741_CR10","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/j.1444-0938.2010.00469.x","volume":"93","author":"NK Sanghera","year":"2010","unstructured":"Sanghera NK, Newman TL. Cytomegaloviral retinitis from chronic immunosuppression following solid organ transplant surgery. Clin Exp Optom. 2010;93(4):261\u20133.","journal-title":"Clin Exp Optom"},{"issue":"2","key":"1741_CR11","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s11255-011-0113-9","volume":"45","author":"MP Patel","year":"2013","unstructured":"Patel MP, Kute VB, Gumber MR, et al. Successful treatment of Nocardia pneumonia with cytomegalovirus retinitis coinfection in a renal transplant recipient. Int Urol Nephrol. 2013;45(2):581\u20135.","journal-title":"Int Urol Nephrol"},{"issue":"9","key":"1741_CR12","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1007\/s00417-014-2587-5","volume":"252","author":"A Agarwal","year":"2014","unstructured":"Agarwal A, Kumari N, Trehan A, et al. Outcome of cytomegalovirus retinitis in immunocompromised patients without human immunodeficiency virus treated with intravitreal ganciclovir injection. Graefes Arch Clin Exp Ophthalmol. 2014;252(9):1393\u2013401.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"1741_CR13","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3109\/09273948.2015.1071406","volume":"25","author":"LM Rifkin","year":"2017","unstructured":"Rifkin LM, Minkus CL, Pursell K, et al. Utility of Leflunomide in the treatment of drug resistant cytomegalovirus retinitis. Ocul Immunol Inflamm. 2017;25(1):93\u20136.","journal-title":"Ocul Immunol Inflamm"},{"issue":"7","key":"1741_CR14","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1086\/591532","volume":"47","author":"R San Juan","year":"2008","unstructured":"San Juan R, Aguado JM, Lumbreras C, et al. Impact of current transplantation management on the development of cytomegalovirus disease after renal transplantation. Clin Infect Dis. 2008;47(7):875\u201382.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"1741_CR15","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1016\/j.ophtha.2012.03.032","volume":"119","author":"S Jeon","year":"2012","unstructured":"Jeon S, Lee WK, Lee Y, et al. Risk factors for cytomegalovirus retinitis in patients with cytomegalovirus viremia after hematopoietic stem cell transplantation. Ophthalmology. 2012;119(9):1892\u20138.","journal-title":"Ophthalmology"},{"issue":"6","key":"1741_CR16","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.ajo.2011.11.014","volume":"153","author":"EA Sugar","year":"2012","unstructured":"Sugar EA, Jabs DA, Ahuja A, et al. Incidence of cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Am J Ophthalmol. 2012;153(6):1016\u20131024.e5.","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"1741_CR17","first-page":"212","volume":"12","author":"N Bassil","year":"2014","unstructured":"Bassil N, Rostaing L, Mengelle C, et al. Prospective monitoring of cytomegalovirus, Epstein-Barr virus, BK virus, and JC virus infections on belatacept therapy after a kidney transplant. Exp Clin Transplant. 2014;12(3):212\u20139.","journal-title":"Exp Clin Transplant"},{"issue":"4","key":"1741_CR18","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1056\/NEJMoa1506027","volume":"374","author":"F Vincenti","year":"2016","unstructured":"Vincenti F, Rostaing L, Grinyo J, et al. Belatacept and long-term outcomes in kidney transplantation. N Engl J Med. 2016;374(4):333\u201343.","journal-title":"N Engl J Med"},{"issue":"5","key":"1741_CR19","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1053\/j.ajkd.2016.09.021","volume":"69","author":"JM Griny\u00f3","year":"2017","unstructured":"Griny\u00f3 JM, Del Carmen RM, Alberu J, et al. Safety and efficacy outcomes 3 years after switching to Belatacept from a Calcineurin inhibitor in kidney transplant recipients: results from a phase 2 randomized trial. Am J Kidney Dis. 2017;69(5):587\u201394.","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"1741_CR20","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1111\/ajt.14452","volume":"17","author":"F Vincenti","year":"2017","unstructured":"Vincenti F, Blancho G, Durrbach A, et al. Ten-year outcomes in a randomized phase II study of kidney transplant recipients administered belatacept 4-weekly or 8-weekly. Am J Transplant. 2017;17(12):3219\u201327.","journal-title":"Am J Transplant"},{"key":"1741_CR21","doi-asserted-by":"crossref","unstructured":"Fan J, Gong D, Truong C, et al. Cytomegalovirus retinitis with belatacept immunosuppression. Retin Cases Brief Rep. 2019; [epub ahead of print].","DOI":"10.1097\/ICB.0000000000000928"},{"issue":"2","key":"1741_CR22","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1093\/ndt\/gfz255","volume":"35","author":"D Bertrand","year":"2020","unstructured":"Bertrand D, Chavarot N, Gatault P, et al. Opportunistic infections after conversion to belatacept in kidney transplantation. Nephrol Dial Transplant. 2020;35(2):336\u201345.","journal-title":"Nephrol Dial Transplant"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-020-01741-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12886-020-01741-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-020-01741-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T17:06:01Z","timestamp":1606928761000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-020-01741-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1741"],"URL":"https:\/\/doi.org\/10.1186\/s12886-020-01741-1","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"28 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"N\/A","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of their clinical details and\/or clinical images was obtained from the patient. A copy of the consent form is available for review by the Editor of this journal.Each author approved the final version of the manuscript and all concur with the submission.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All the authors declared no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"468"}}